SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 50 filers reported holding SUMMIT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,938 | -86.5% | 9,058 | -81.8% | 0.00% | – |
| Q2 2023 | $125,108 | +19.2% | 49,844 | -16.9% | 0.00% | – |
| Q1 2023 | $104,951 | -55.4% | 59,972 | +8.4% | 0.00% | – |
| Q4 2022 | $235,238 | +7741.3% | 55,350 | +2071.4% | 0.00% | – |
| Q3 2022 | $3,000 | +50.0% | 2,549 | +48.2% | 0.00% | – |
| Q2 2022 | $2,000 | -75.0% | 1,720 | -47.7% | 0.00% | – |
| Q1 2022 | $8,000 | -71.4% | 3,290 | -68.7% | 0.00% | – |
| Q4 2021 | $28,000 | -37.8% | 10,502 | +16.8% | 0.00% | – |
| Q3 2021 | $45,000 | -15.1% | 8,995 | +25.5% | 0.00% | – |
| Q2 2021 | $53,000 | -41.1% | 7,165 | -53.3% | 0.00% | – |
| Q1 2021 | $90,000 | +592.3% | 15,332 | +473.4% | 0.00% | – |
| Q4 2020 | $13,000 | +1200.0% | 2,674 | +1237.0% | 0.00% | – |
| Q3 2020 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polar Capital Holdings Plc | 5,800,000 | $27,260,000 | 0.16% |
| Inscription Capital, LLC | 17,000 | $80,000 | 0.03% |
| ExodusPoint Capital Management, LP | 185,844 | $873,000 | 0.01% |
| HoyleCohen, LLC | 10,359 | $49,000 | 0.01% |
| Virtu Financial LLC | 10,835 | $51,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 3,783 | $18,000 | 0.00% |
| Renaissance Technologies | 253,212 | $1,190,000 | 0.00% |
| Baillie Gifford | 372,261 | $1,749,000 | 0.00% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 37,238 | $175,000 | 0.00% |
| BREWIN DOLPHIN LTD | 1,970 | $9,259 | 0.00% |